-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Praxis Precision Medicines, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2019 to Q3 2025.
- Praxis Precision Medicines, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$73.9M, a 42.4% decline year-over-year.
- Praxis Precision Medicines, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$273M, a 80.8% decline year-over-year.
- Praxis Precision Medicines, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$183M, a 48.3% decline from 2023.
- Praxis Precision Medicines, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$123M, a 42.4% increase from 2022.
- Praxis Precision Medicines, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$214M, a 28.1% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)